For those of you who will be in town, there’s some outstanding events. They include:
- Bio2Device Group, Tuesday Morning, April 6, 2010, Topic: “Self-guided Surgery”, Speaker: John Black, Ph.D., VP, Imaging, Avinger Inc.
- BayBio One-Day Conference, Wednesday, April 7, 2010, Topic: “BayBio2010: Life Science Innovation: Drivers and Barriers
- BioE2E, Wednesday Evening, April 7, 2010, Topic: “Board Politics…No Prettier Than National Politics; Can Be Just as Frustrating,” Speakers:
Steve Kirnon, Executive Vice President at Strawn Arnold Ashpitz Groover,
Nancy Olson, Fog City Fund,Vern Norviel, Wilson Sonsini Goodrich & Rosati - Stanford Center for Law and the Biosciences, Friday, April 9, 2010Topic: “Drug Development and International Access;” Speakers Include:
• Gregg Alton, Executive Vice President, Corporate and Medical Affairs at Gilead
• Tom Bollyky, Fellow at the Center for Global Development
• Robert Chess, Chairman, Nektar Therapeutics; Board member and initial Chairman, Bio Ventures for Global Health
• Richard Chin, CEO of OneWorld Health
• Joe Damond, Vice President of Government Relations at Pfizer
• Charlie Kinzig, Vice President of Corporate Intellectual Property at GlaxoSmithKline
• Carol Mimura, Assistant Vice Chancellor, UC Berkeley Intellectual Property & Industry Research Alliances
• Jenik Radon, Professor at Columbia University’s School of International and Public Affairs
• Hannu Wager, Counselor in the IP Division of the WTO, and Secretary of the WTO TRIPS Council
Leave a comment